Literature DB >> 21940084

Life of a partnership: the process of collaboration between the National Tuberculosis Program and the hospitals in Yogyakarta, Indonesia.

Ari Probandari1, Adi Utarini, Lars Lindholm, Anna-Karin Hurtig.   

Abstract

Public-private partnerships (PPP) for improving the health of populations are currently attracting attention in many countries with limited resources. The Public-Private Mix for Tuberculosis Control is an example of an internationally supported PPP that aims to engage all providers, including hospitals, to implement standardized diagnosis and treatment. This paper explores mainly the local actors' views and experiences of the process of PPP in delivering TB care in hospitals in Yogyakarta Province, Indonesia. The study used a qualitative research design. By maximum variation sampling, 33 informants were purposefully selected. The informants were involved in the Public-Private Mix for Tuberculosis Control in Yogyakarta Province. Data were collected during 2008-2009 by in-depth interview and analyzed using content analysis techniques. Triangulation, reference group checking and peer debriefing were conducted to improve the trustworthiness of the data. This analysis showed that the process of partnership was dynamic. In the early phase of partnership, the National Tuberculosis Program and hospital actors perceived barriers to interaction such as low enthusiasm, lack of confidence, mistrust and inequality of relationships. The existence of an intermediary actor was important for approaching the National Tuberculosis Program and hospitals. After intensive interactions, compromises and acceptance were reached among the actors and even enabled the growth of mutual respect and feelings of programme ownership. However, the partnership faced declining interactions when faced with scarce resources and weak governance. The strategies, power and interactions between actors are important aspects of the process of collaboration. We conclude that good partnership governance is needed for the partnership to be effective and sustainable.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21940084     DOI: 10.1016/j.socscimed.2011.08.017

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  6 in total

1.  Factors influencing integration of TB services in general hospitals in two regions of China: a qualitative study.

Authors:  Guanyang Zou; Xiaolin Wei; John D Walley; Jia Yin; Qiang Sun
Journal:  BMC Health Serv Res       Date:  2012-01-25       Impact factor: 2.655

2.  Feasibility study of strengthening the public-private partnership for tuberculosis case detection in Bandung City, Indonesia.

Authors:  Bony Wiem Lestari; Nita Arisanti; Adiatma Y M Siregar; Estro Dariatno Sihaloho; Gelar Budiman; Philip C Hill; Bachti Alisjahbana; Susan McAllister
Journal:  BMC Res Notes       Date:  2017-08-14

3.  Varying viewpoints of Belgian stakeholders on models of interhospital collaboration.

Authors:  Melissa De Regge; Kaat De Pourcq; Paul Gemmel; Carine Van de Voorde; Koen Van den Heede; Kristof Eeckloo
Journal:  BMC Health Serv Res       Date:  2018-12-04       Impact factor: 2.655

Review 4.  Hospital services under public-private partnerships, outcomes and, challenges: A literature review.

Authors:  Masyitoh Basabih; Eko Prasojo; Amy Yayuk Sri Rahayu
Journal:  J Public Health Res       Date:  2022-08-26

5.  Barriers to hospital and tuberculosis programme collaboration in China: context matters.

Authors:  Guanyang Zou; Rebecca King; John Walley; Jia Yin; Qiang Sun; Xiaolin Wei
Journal:  Glob Health Action       Date:  2015-09-24       Impact factor: 2.640

6.  Factors associated to referral of tuberculosis suspects by private practitioners to community health centres in Bali Province, Indonesia.

Authors:  I Wayan Gede Artawan Eka Putra; Ni Wayan Arya Utami; I Ketut Suarjana; I Made Kerta Duana; Cok Istri Darma Astiti; I W Putra; Ari Probandari; Edine W Tiemersma; Chatarina Umbul Wahyuni
Journal:  BMC Health Serv Res       Date:  2013-10-28       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.